Childress Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Childress Capital Advisors's AMGN Position: Q2 2026 in Review
Childress Capital Advisors reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $158K and leaving 3,488 shares worth $1.26M. The position accounts for 0.21% of the portfolio, ranked #74.
Childress Capital Advisors first reported a position in AMGN in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.39M in Q1 2026. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Childress Capital Advisors held 3,488 shares of Amgen worth $1.26M as of Q2 2026.
- Childress Capital Advisors sold 462 Amgen shares in Q2 2026, an estimated $158K.
- Amgen made up 0.21% of Childress Capital Advisors's portfolio in Q2 2026, its #74 holding.
- Childress Capital Advisors first reported a position in Amgen in Q4 2020 and has held it in 21 quarters since.
- Childress Capital Advisors's Amgen position peaked at $1.39M in Q1 2026.
- 3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.